From: Important prognostic factors for the long-term survival of lung cancer subjects in Taiwan
Males (N = 18,056) | Females (N = 6854) | ||
---|---|---|---|
Characteristics | N (%)a | N (%)a | pValue |
Mean age (years) ± S.D. | 64.8 ± 9.9 | 62.2 ± 14.5 | < 0.0001 |
Period of diagnosis (years) | |||
1987–1990 | 7455 (41) | 2690 (39) | 0.003 |
1991–1994 | 10601 (59) | 4164 (61) | |
Diagnostic age (yrs) | |||
<= 39 | 418 (2) | 382 (6) | < 0.0001 |
40–49 | 855 (5) | 730 (11) | |
50–59 | 3069 (17) | 1409 (21) | |
60–69 | 7364 (41) | 2137 (31) | |
>= 70 | 6320 (35) | 2196 (32) | |
Resident area | |||
Aboriginal community | 410 (2) | 128 (2) | 0.0060 |
Hakka community | 1462 (8) | 491 (7) | |
Hokkien community | 16184 (90) | 6235 (91) | |
Histological type | |||
SQCC | 5855 (32) | 1003 (15) | < 0.0001 |
Adenocarcinoma | 4880 (27) | 3156 (46) | |
SCC | 2005 (11) | 276 (4) | |
LCC | 326 (2) | 107 (2) | |
Carcinoma, NOS | 1664 (9) | 599 (9) | |
Other carcinoma | 3326 (18) | 1713 (25) | |
Treatment modality | |||
Surgery resection | 2360 (13) | 859 (13) | < 0.0001 |
RT | 3970 (22) | 1078 (16) | |
CT | 1974 (11) | 597 (9) | |
ST | 4316 (24) | 2085 (30) | |
Other complex therapy | 40 (< 1) | 23 (< 1) | |
Unknown therapy | 5396 (30) | 2212 (32) |